Abstract:Background Ischemic heart disease (IHD) imposes the greatest disease burden globally, especially in low‐ and middle‐income countries (LMICs). We aim to examine the population‐attributable fraction and risk‐attributable death and disability‐adjusted life years (DALYs) for IHD in 137 low‐ and middle‐income countries. Methods and Results Using comparative risk assessment framework from the 2019 Global Burden of Disease study, the population‐attributable fraction and IHD burden (death and DALYs) attributable to risk factors in low‐income countries, lower‐middle‐income countries (LMCs), and upper‐middle‐income countries were assessed from 2000 to 2019. In 2019, the population‐attributable fraction (%) of IHD deaths in relation to all modifiable risk factors combined was highest in lower‐middle‐income countries (94.2; 95% uncertainty interval, 91.9–96.2), followed by upper‐middle‐income countries (93.5; 90.4–95.8) and low‐income countries (92.5; 90.0–94.7). There was a >13‐fold difference between Peru and Uzbekistan in age‐standardized rates (per 100 000) of attributable death (44.3 versus 660.4) and DALYs (786.7 versus 10506.1). Dietary risks accounted for the largest proportion of IHD's behavioral burden in low‐ and middle‐income countries, primarily attributable to diets low in whole grains. High systolic blood pressure and high low‐density lipoprotein cholesterol remained the 2 leading causes of DALYs, with the former topping the list in 116 countries, while the latter led in 21 of the 137 countries. Compared with 2000 to 2010, the increases in risk‐attributable deaths and DALYs among upper‐middle income countries were slower from 2010 to 2019, while the trends in low‐income countries and lower‐middle income countries were opposite. Conclusions IHD's attributable burden remains high in low‐ and middle‐income countries. Considerable heterogeneity was observed among different income‐classified regions and countries. Nonstandard Abbreviations and Acronyms DALYs disability‐adjusted life years GBD Global Burden of Disease IHD ischemic heart disease LICs low‐income countries LMCs lower‐middle‐income countries LMICs low‐ and middle‐income countries MICs middle‐income countries PAF population‐attributable fraction PURE Prospective Urban Rural Epidemiology TMREL theoretical minimum risk exposure level UMCs upper‐middle‐income countries Clinical Perspective What Is New? Using the updated comparative risk assessment framework from the 2019 Global Burden of Disease study, we provided the first income‐classified region‐, country‐, sex‐, and age‐specific assessment of ischemic heart disease (IHD) burden attributable to risk clusters and risk factors among 137 low‐ and middle‐income countries from 2000 to 2019. Most global risk‐attributable deaths and DALYs for IHD occurred in low‐ and middle‐income countries, with a substantial geographic discrepancy observed across the 137 individual countries. A diverging trend in IHD burden between middle‐income countries and low‐income countries during the 2010 to 2019 period compared with 2000 to 2010. What Are the Clinical Implications? Preventive interventions reducing behavioral and metabolic risks will be more effective in managing IHD burden for middle‐income countries, while interventions to reduce environmental risks should be implemented in low‐income countries. More investments in managing preventable IHD burden are needed considering the substantial geographical income discrepancies across the 137 low‐ and middle‐income countries. Ischemic heart disease (IHD) is the leading contributor to deaths and disability‐adjusted life years (DALYs) globally, espe -Abstract Truncated-

Diversity and structure of genes of the alpha family of mouse T-cell antigen receptor.

Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990-2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017

The ego and mystic selflessness.

Risk-Attributable Burden of Ischemic Heart Disease in 137 Low- and Middle-Income Countries From 2000 to 2019.

Abstract 13720: Global Burden, Trends, and Attributable Risk Factors for Ischemic Heart Disease, 1990~2019: A Systemic Analysis of the Global Burden of Disease Study 2019

The Burden of Cardiovascular Diseases among US States, 1990-2016

The Burden and Trends of Heart Failure Caused by Ischemic Heart Disease at the Global, Regional, and National Levels from 1990 to 2021

Burden of Ischemic and Hemorrhagic Stroke Across the US from 1990 to 2019.

Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study

Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study

Abstract 19: State-level Disparities in Health Loss Due to Cardiovascular Causes: Results of the Global Burden of Disease 2015 Study

Global burden of ischemic heart disease in adolescents and young adults, 1990-2019

The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States

Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study

Global and National Burden of Atherosclerosis from 1990 to 2019: Trend Analysis Based on the Global Burden of Disease Study 2019.

An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.

A Brief Review of Theoretical Underpinnings, Definitions and Typical Configurations of Collaborative Writing

Human potential phases in the second half of life.

Temporal trends in the prevalence and death of ischemic heart disease in women of childbearing age from 1990 to 2019: a multilevel analysis based on the Global Burden of Disease Study 2019

Risk assessment of dietary factors in global pattern of ischemic heart disease mortality and disability-adjusted life years over 30 years

Trends in deaths and disability-adjusted life-years of ischemic heart disease attributable to high body-mass index worldwide, 1990-2019